AZ-Pfizer relief: 'at risk' partnerships in the clear as takeover plans fold
This article was originally published in Scrip
As the news breaks that UK big pharma AstraZeneca has rejected a final takeover bid from US giant Pfizer, several of both the firms' smaller pharma and biotech partners will be breathing a sigh of relief.
You may also be interested in...
Coaching and mentoring are important tools for the leaders of today to be able to foster the next generation of talent in the biopharma sector. While the routes into industry have not changed dramatically – most leaders hold a master’s degree and/or PhD – the expectations of rising leaders have altered and the industry itself has become more collaborative.
Angeli Möller, recently spotlighted by In Vivo as a 2020 Rising Leader, has quickly moved up the ranks at Bayer and is now spearheading one of its key initiatives to bring artificial intelligence and machine learning technologies into the pharma business.
In this first edition of In Vivo's ‘Rising Leaders’ list, the focus is on entrepreneurs and innovators who represent the next wave of creativity in health care.